Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 2 | 2013 | 1229 | 0.410 |
Why?
|
| Models, Theoretical | 1 | 2013 | 494 | 0.330 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 494 | 0.330 |
Why?
|
| Genetic Testing | 1 | 2013 | 564 | 0.300 |
Why?
|
| Diabetes Mellitus | 2 | 2013 | 762 | 0.270 |
Why?
|
| Genomics | 1 | 2013 | 848 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 590 | 0.230 |
Why?
|
| Insulin-Secreting Cells | 2 | 2014 | 441 | 0.220 |
Why?
|
| Bayes Theorem | 2 | 2007 | 403 | 0.190 |
Why?
|
| Membrane Proteins | 2 | 2014 | 1260 | 0.190 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 201 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 298 | 0.180 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 1517 | 0.180 |
Why?
|
| Trans-Activators | 1 | 2014 | 439 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 663 | 0.160 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 556 | 0.160 |
Why?
|
| Breast Neoplasms | 22 | 1981 | 3155 | 0.150 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 50 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2013 | 30 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2013 | 80 | 0.100 |
Why?
|
| Microcephaly | 1 | 2013 | 77 | 0.100 |
Why?
|
| Sulfonylurea Compounds | 1 | 2013 | 71 | 0.100 |
Why?
|
| Epilepsy, Generalized | 1 | 2013 | 42 | 0.100 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 91 | 0.100 |
Why?
|
| Point Mutation | 1 | 2013 | 237 | 0.090 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2013 | 157 | 0.090 |
Why?
|
| Glutamate Decarboxylase | 1 | 2011 | 34 | 0.080 |
Why?
|
| Methotrexate | 7 | 1976 | 226 | 0.080 |
Why?
|
| C-Peptide | 1 | 2011 | 184 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2013 | 660 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2011 | 276 | 0.080 |
Why?
|
| Precision Medicine | 1 | 2013 | 457 | 0.070 |
Why?
|
| Coronary Disease | 2 | 1980 | 221 | 0.070 |
Why?
|
| Lipids | 2 | 1980 | 277 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1160 | 0.060 |
Why?
|
| Adult | 14 | 2013 | 27849 | 0.060 |
Why?
|
| Mouth Neoplasms | 5 | 1976 | 202 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2013 | 3044 | 0.060 |
Why?
|
| Chicago | 1 | 2011 | 1452 | 0.060 |
Why?
|
| Humans | 39 | 2013 | 93132 | 0.060 |
Why?
|
| Female | 23 | 2013 | 48542 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 6 | 1976 | 1071 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 337 | 0.050 |
Why?
|
| Phenotype | 1 | 2011 | 2545 | 0.050 |
Why?
|
| Vinblastine | 5 | 1976 | 84 | 0.050 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2014 | 25 | 0.050 |
Why?
|
| Child | 6 | 2011 | 7273 | 0.050 |
Why?
|
| Obesity | 1 | 2011 | 1014 | 0.050 |
Why?
|
| Lentivirus | 1 | 2014 | 44 | 0.050 |
Why?
|
| Male | 8 | 2013 | 44355 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 3 | 1978 | 48 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 254 | 0.050 |
Why?
|
| RNA Interference | 1 | 2014 | 379 | 0.050 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 422 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2007 | 393 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2007 | 1120 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 556 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 305 | 0.040 |
Why?
|
| South Africa | 7 | 1980 | 61 | 0.040 |
Why?
|
| Haplotypes | 1 | 2014 | 647 | 0.040 |
Why?
|
| Estradiol | 5 | 1980 | 247 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 691 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2014 | 727 | 0.040 |
Why?
|
| Testosterone | 4 | 1980 | 258 | 0.040 |
Why?
|
| United States | 1 | 2013 | 7581 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2004 | 584 | 0.040 |
Why?
|
| Computational Biology | 1 | 2004 | 581 | 0.040 |
Why?
|
| Cell Line | 1 | 2014 | 2458 | 0.040 |
Why?
|
| Head | 3 | 1972 | 131 | 0.040 |
Why?
|
| Adolescent | 2 | 2011 | 9550 | 0.040 |
Why?
|
| Mastectomy | 4 | 1978 | 262 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2004 | 970 | 0.030 |
Why?
|
| Transcriptome | 1 | 2014 | 762 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2020 | 0.030 |
Why?
|
| Apoptosis | 1 | 2014 | 1719 | 0.030 |
Why?
|
| Androstanols | 2 | 1975 | 10 | 0.030 |
Why?
|
| Menopause | 7 | 1980 | 87 | 0.030 |
Why?
|
| Maxillary Neoplasms | 1 | 1976 | 7 | 0.030 |
Why?
|
| Mouth Floor | 1 | 1975 | 4 | 0.030 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 1975 | 18 | 0.030 |
Why?
|
| Mammography | 1 | 1978 | 494 | 0.030 |
Why?
|
| Diet | 5 | 1981 | 461 | 0.030 |
Why?
|
| Blindness, Cortical | 1 | 2013 | 8 | 0.030 |
Why?
|
| Neurologic Manifestations | 1 | 2013 | 10 | 0.030 |
Why?
|
| Nandrolone | 2 | 1975 | 2 | 0.030 |
Why?
|
| Mice | 2 | 2014 | 12230 | 0.030 |
Why?
|
| Ethinyl Estradiol | 2 | 1975 | 16 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 1975 | 1073 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 292 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 331 | 0.020 |
Why?
|
| Hormones | 3 | 1981 | 136 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 381 | 0.020 |
Why?
|
| Diverticulum, Colon | 1 | 1972 | 10 | 0.020 |
Why?
|
| Diverticulitis, Colonic | 1 | 1972 | 11 | 0.020 |
Why?
|
| Estrogens | 5 | 1980 | 194 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 204 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2013 | 2427 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1972 | 239 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 1976 | 1447 | 0.020 |
Why?
|
| Castration | 5 | 1976 | 32 | 0.020 |
Why?
|
| Animals | 3 | 2014 | 27973 | 0.020 |
Why?
|
| Triglycerides | 2 | 1980 | 231 | 0.020 |
Why?
|
| Middle Aged | 12 | 1980 | 27535 | 0.020 |
Why?
|
| Mechlorethamine | 2 | 1965 | 10 | 0.020 |
Why?
|
| Gonadotropins, Pituitary | 3 | 1980 | 11 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1910 | 0.020 |
Why?
|
| Adrenal Glands | 3 | 1976 | 72 | 0.020 |
Why?
|
| Breast | 2 | 1962 | 302 | 0.020 |
Why?
|
| Cholesterol | 2 | 1980 | 364 | 0.020 |
Why?
|
| Karyotyping | 1 | 2007 | 220 | 0.020 |
Why?
|
| Progressive Patient Care | 1 | 1966 | 2 | 0.020 |
Why?
|
| Diet, Vegetarian | 3 | 1981 | 8 | 0.020 |
Why?
|
| Neoplasms | 4 | 1972 | 3168 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 4 | 1974 | 33 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2007 | 391 | 0.010 |
Why?
|
| Risk | 4 | 1981 | 651 | 0.010 |
Why?
|
| Adrenalectomy | 2 | 1955 | 41 | 0.010 |
Why?
|
| Menstruation | 3 | 1980 | 35 | 0.010 |
Why?
|
| Androgens | 3 | 1975 | 163 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2007 | 282 | 0.010 |
Why?
|
| Aged | 8 | 1976 | 20395 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 1972 | 2301 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 626 | 0.010 |
Why?
|
| Infusions, Parenteral | 2 | 1976 | 46 | 0.010 |
Why?
|
| Life Style | 2 | 1981 | 183 | 0.010 |
Why?
|
| North America | 2 | 1980 | 197 | 0.010 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 1976 | 26 | 0.010 |
Why?
|
| Tongue Neoplasms | 2 | 1976 | 51 | 0.010 |
Why?
|
| Lymph Node Excision | 2 | 1972 | 233 | 0.010 |
Why?
|
| Feeding Behavior | 2 | 1980 | 337 | 0.010 |
Why?
|
| Methods | 2 | 1972 | 135 | 0.010 |
Why?
|
| Lung | 1 | 2007 | 1359 | 0.010 |
Why?
|
| Menarche | 1 | 1980 | 30 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 1980 | 91 | 0.010 |
Why?
|
| Disease Management | 1 | 1962 | 357 | 0.010 |
Why?
|
| Environment | 1 | 1981 | 230 | 0.010 |
Why?
|
| Algorithms | 1 | 2007 | 1948 | 0.010 |
Why?
|
| Thiotepa | 2 | 1972 | 32 | 0.010 |
Why?
|
| Hospital Departments | 1 | 1978 | 13 | 0.010 |
Why?
|
| Health Surveys | 1 | 1978 | 245 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 4 | 1980 | 45 | 0.010 |
Why?
|
| Congresses as Topic | 1 | 1977 | 121 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1975 | 3814 | 0.010 |
Why?
|
| History, 20th Century | 1 | 1978 | 312 | 0.010 |
Why?
|
| Prolactin | 1 | 1976 | 89 | 0.010 |
Why?
|
| Paget's Disease, Mammary | 1 | 1956 | 3 | 0.010 |
Why?
|
| Nipples | 1 | 1956 | 37 | 0.010 |
Why?
|
| Endocrine Surgical Procedures | 1 | 1955 | 3 | 0.010 |
Why?
|
| Endocrine Glands | 1 | 1955 | 13 | 0.010 |
Why?
|
| Splenic Rupture | 1 | 1955 | 7 | 0.010 |
Why?
|
| Biopsy | 1 | 1979 | 1172 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1976 | 111 | 0.010 |
Why?
|
| Radioisotope Teletherapy | 1 | 1974 | 4 | 0.010 |
Why?
|
| Hyperbaric Oxygenation | 1 | 1974 | 13 | 0.010 |
Why?
|
| Age Factors | 2 | 1976 | 1898 | 0.010 |
Why?
|
| Spleen | 1 | 1955 | 372 | 0.010 |
Why?
|
| Medical Oncology | 1 | 1978 | 403 | 0.010 |
Why?
|
| Androstenedione | 3 | 1980 | 24 | 0.010 |
Why?
|
| Prognosis | 2 | 1978 | 3890 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 1976 | 343 | 0.010 |
Why?
|
| Luteinizing Hormone | 3 | 1980 | 144 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1978 | 2009 | 0.010 |
Why?
|
| Virilism | 1 | 1972 | 5 | 0.010 |
Why?
|
| Propionates | 1 | 1972 | 28 | 0.010 |
Why?
|
| Sex Factors | 1 | 1976 | 1102 | 0.010 |
Why?
|
| Axilla | 1 | 1972 | 109 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1972 | 232 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1972 | 359 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1972 | 191 | 0.010 |
Why?
|
| Body Weight | 1 | 1972 | 449 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1981 | 1769 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1972 | 505 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1956 | 1171 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1972 | 550 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1972 | 1060 | 0.000 |
Why?
|
| Angiography | 1 | 1968 | 192 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1972 | 1098 | 0.000 |
Why?
|
| Catheterization | 1 | 1968 | 217 | 0.000 |
Why?
|
| Estrone | 2 | 1976 | 9 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 2 | 1976 | 129 | 0.000 |
Why?
|
| Africa | 2 | 1976 | 109 | 0.000 |
Why?
|
| Palatal Neoplasms | 1 | 1965 | 3 | 0.000 |
Why?
|
| Lip Neoplasms | 1 | 1965 | 7 | 0.000 |
Why?
|
| Pharyngeal Neoplasms | 1 | 1965 | 14 | 0.000 |
Why?
|
| Adenoma, Pleomorphic | 1 | 1965 | 8 | 0.000 |
Why?
|
| Facial Neoplasms | 1 | 1965 | 26 | 0.000 |
Why?
|
| Radiotherapy | 1 | 1966 | 319 | 0.000 |
Why?
|
| Fibrosarcoma | 1 | 1965 | 89 | 0.000 |
Why?
|
| Time Factors | 1 | 1972 | 5380 | 0.000 |
Why?
|
| X-Ray Therapy | 1 | 1963 | 7 | 0.000 |
Why?
|
| Neck | 1 | 1963 | 97 | 0.000 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1965 | 184 | 0.000 |
Why?
|
| Dietary Fats | 1 | 1981 | 134 | 0.000 |
Why?
|
| Melanoma | 1 | 1965 | 494 | 0.000 |
Why?
|
| Cross-Cultural Comparison | 1 | 1980 | 35 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1980 | 289 | 0.000 |
Why?
|
| Climacteric | 1 | 1976 | 4 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1976 | 139 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1976 | 94 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1976 | 174 | 0.000 |
Why?
|
| Japan | 1 | 1976 | 299 | 0.000 |
Why?
|
| Rupture | 1 | 1955 | 57 | 0.000 |
Why?
|
| Androsterone | 1 | 1974 | 5 | 0.000 |
Why?
|
| Cobalt Radioisotopes | 1 | 1974 | 19 | 0.000 |
Why?
|
| Puberty | 1 | 1974 | 54 | 0.000 |
Why?
|
| Circadian Rhythm | 1 | 1976 | 285 | 0.000 |
Why?
|
| Cell Survival | 1 | 1974 | 1002 | 0.000 |
Why?
|
| Aging | 1 | 1976 | 725 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1974 | 2827 | 0.000 |
Why?
|
| Pregnancy | 1 | 1976 | 3128 | 0.000 |
Why?
|